Article

Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. Am J Clin Nutr

Food and Health R&D Laboratories, Meiji Seika Kaisha Ltd, Saitama, Japan.
American Journal of Clinical Nutrition (Impact Factor: 6.77). 04/2007; 85(3):709-17.
Source: PubMed

ABSTRACT

Cocoa powder is rich in polyphenols such as catechins and procyanidins and has been shown in various models to inhibit LDL oxidation and atherogenesis.
We examined whether long-term intake of cocoa powder alters plasma lipid profiles in normocholesterolemic and mildly hypercholesterolemic human subjects.
Twenty-five subjects were randomly assigned to ingest either 12 g sugar/d (control group) or 26 g cocoa powder and 12 g sugar/d (cocoa group) for 12 wk. Blood samples were collected before the study and 12 wk after intake of the test drinks. Plasma lipids, LDL oxidative susceptibility, and urinary oxidative stress markers were measured.
At 12 wk, we measured a 9% prolongation from baseline levels in the lag time of LDL oxidation in the cocoa group. This prolongation in the cocoa group was significantly greater than the reduction measured in the control group (-13%). A significantly greater increase in plasma HDL cholesterol (24%) was observed in the cocoa group than in the control group (5%). A negative correlation was observed between plasma concentrations of HDL cholesterol and oxidized LDL. At 12 wk, there was a 24% reduction in dityrosine from baseline concentrations in the cocoa group. This reduction in the cocoa group was significantly greater than the reduction in the control group (-1%).
It is possible that increases in HDL-cholesterol concentrations may contribute to the suppression of LDL oxidation and that polyphenolic substances derived from cocoa powder may contribute to an elevation in HDL cholesterol.

Download full-text

Full-text

Available from: Yoji Kato
    • "Different studies have also demonstrated that cocoa or its main components, such as EC, exert hypoglycaemic and hypolipidaemic effects on several animal models of diabetes and insulin resistance (Cordero-Herrera, Martín, Goya, & Ramos, 2015a; Matsuia et al., 2005; Mokiran et al., 2014; Ramos et al., 2008; Ruzaidi, Amin, Nawalyah, Hamid, & Faizul, 2005; Si et al., 2011). Moreover, cocoa and dark chocolate have been reported to improve insulin sensitivity and lipid profile in healthy humans and T2D patients, alleviating the atherosclerotic cholesterol profile (Baba et al., 2007; Grassi et al., 2008; Mellor, Sathyapalan, Kilpatrick, Beckett, & Atkin, 2010). However, to the best of our knowledge, limited studies have evaluated the effects of cocoa and EC on lipid metabolism during diabetes by using animal and cellular models. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Diabetes alters lipid metabolism that could lead to hepatic steatosis. The present study aimed to investigate the effect of a cocoa-enriched diet in type 2 diabetic Zucker diabetic fatty (ZDF) rats and that of cocoa-flavanol epicatechin (EC) in high-glucose-exposed HepG2 cells on hepatic lipid metabolism. Male ZDF cocoa-fed-rats had decreased body weight gain and improved circulating and hepatic lipid levels. Similarly, EC alleviated the altered lipid values induced in high-glucose-challenged HepG2 cells. The lipid-lowering effect was related to diminished fatty acid synthesis (sterol-regulatory-element-binding protein-1-c and fatty-acid synthase down-regulation), and increased fatty-acid oxidation (proliferator-activated-receptor α up-regulation). These effects depended on 5′-AMP-activated-protein-kinase (AMPK), protein kinase B (AKT) and protein kinase C (PKC)-ζ, which phosphorylated levels returned to control values upon cocoa or EC administration. Moreover, PKCζ played a role on AKT and AMPK regulation. These findings suggest that cocoa and EC protect hepatocytes in vivo and in vitro by improving lipid metabolism through multiple-signalling pathways.
    No preview · Article · Aug 2015 · Journal of Functional Foods
  • Source
    • "While LDL transports cholesterol to the peripheral tissues thereby increasing risk of cardiovascular disease, HDL scavenges cholesterol from the peripheral tissues back to the liver for excretion through conversion to bile and negating the risk of developing cardiovascular diseases (Kwiterovich, 2000). The reduction of LDLcholesterol is attributed to the presence of saponins in the extract (Cheeke, 1971), whereas the increase in HDL-cholesterol is as a result of the presence of flavonoids and phenols in the plant extract (Cheeke, 1971;Baba et al., 2007). Obesity increases VLDL (triacylglycerols) through increased production and decreased clearance of triacylglycerols-rich lipoproteins due to lack of stimulation of lipoprotein lipase. "
    Ugbaja · R. N. · Owoeye · F. D. · Akinloye · O. A. · Dedeke · G. A
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity, resulting from energy imbalance caused by an increased ratio of caloric intake to energy expenditure is a global health problem. This study investigated the effects of Sorghum bicolor leaf extracts (SBE) on blood lipid levels in high fat diet-induced obese rats. Sorghum bicolor leaf was extracted with 70% ethanol using Soxhlet extractor. Male Wistar rats (n=36) divided into six groups: (A) normal control, (B) obese control (High Fat Diet – HFD), (C) HFD+150 mg/kg body weight SBE (first treatment), (D) HFD+300 mg/kg body weight SBE (second treatment), (E) HFD+600 mg/kg body weight SBE (third treatment) and (F) HFD+ 1200 mg/kg body weight SBE (fourth treatment) were used. The SBE was administered orally to the animals daily for 28 days. Body weight was taken weekly and Lee index was calculated alongside. Plasma, erythrocytes and lipoproteins' lipid profiles were determined using spectrophotometric methods. Results from the study revealed that generally, SBE significantly reduced (p<0.05) the levels of cholesterol, phospholipids, triacylglycerol by varying levels, in the various blood compartments of the obese animals. It was observed that SBE caused a significant (p<0.05) decrease in plasma cholesterol level of the fourth treatment group. Also, SBE significantly (p<0.05) reduced the elevated atherogenic and coronary risk indices by 50%. This study suggests that SBE might be useful in the management of obesity and its co-morbid conditions.
    Full-text · Article · Jun 2015
  • Source
    • "These reports showed that chocolate consumption was associated with a substantial reduction in the risk of cardiometabolic disorders such as coronary heart disease and stroke. In addition, numerous randomized, controlled trials have confirmed that chocolate, especially dark chocolate containing large amounts of flavan-3-ols, improves risk factors for the metabolic syndrome such as hypertension [6,7], vascular endothelial dysfunction [8,9], dyslipidemia [10,11], and glucose intolerance [12,13]. Several meta-analyses conducted after these clinical trials confirmed that dark chocolate rich in flavan-3-ols reduced the risk of cardiovascular disease by improving these risk factors [14-19]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Numerous clinical studies have reported that ingestion of chocolate has reduced risk of metabolic syndrome. In order to elucidate the mechanism, we evaluated the influence of flavan-3-ols derived from cocoa powder on energy metabolism in mice using an indirect calorimetric method. The mice were divided into two groups, and administered either distilled water or 50 mg/kg of flavan-3-ol fraction for 2 weeks. At the end of the experimental period, animals were sacrificed after blood pressure and the mean respiratory exchange ratio (RER) over 24 hours were measured. The mean respiratory exchange ratio (RER) over 24 hours was reduced significantly in the flavan-3-ols group. The mean blood pressure was significantly decreased in flavan-3-ols treatment group compared with control group. The protein level of carnitine palmitoyltransferase 2 (CPT2) was increased significantly by flavan-3-ols in skeletal muscle, but not in the liver. Uncoupling protein (UCP) 1 was increased significantly in brown adipose tissue by flavan-3-ols. The mitochondria copy number in the gastrocnemius and soleus muscles and brown adipose tissue were increased significantly by administration of flavan-3-ol fraction. These results suggest that flavan-3-ols enhances lipolysis and promotes mitochondrial biogenesis. We conclude that improvement of metabolic syndrome risk factors following ingestion of chocolate may be induced, in part, by the mitochondrial biogenesis-promoting effect of flavan-3-ols.
    Full-text · Article · Apr 2014 · Lipids in Health and Disease
Show more